SISCAPA Assay Technologies

Washington, United States

SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets.

$2.0M raised

Jul 2025

Undisclosed

Biotechnology Life Science Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SISCAPA Assay Technologies

How much funding has SISCAPA Assay Technologies raised?

SISCAPA Assay Technologies has raised $2.0M in total funding. The most recent round was Undisclosed. The last funding was announced in July 2025.

Where is SISCAPA Assay Technologies headquartered?

SISCAPA Assay Technologies is headquartered in Washington, United States.

What does SISCAPA Assay Technologies do?

SISCAPA Assay Technologies develops immunoassays for the quantitation of protein biomarkers and targets.

What stage is SISCAPA Assay Technologies at?

SISCAPA Assay Technologies is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 3, 2025.

MLA

"SISCAPA Assay Technologies — Funding & Investors." VCBacked, July 3, 2025, https://www.vcbacked.co/company/siscapa-assay-technologies. Accessed July 3, 2026.

APA

VCBacked. (2025). SISCAPA Assay Technologies — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/siscapa-assay-technologies

Wikipedia (cite web)

{{cite web |title=SISCAPA Assay Technologies — Funding & Investors |url=https://www.vcbacked.co/company/siscapa-assay-technologies |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 3, 2025.